semaglutide and masld Reduces Weight, Truncal Fat In Patients With Semaglutide Improves Histology in MASH:

Sharma AK, Khandelwal R, Wolfrum C

There are some non-M1 and non-M2 restorative type macrophages, which have both anti-inflammation and anti-fibrogenic features, highly express matrix metalloproteinase (MMP), and have a LY6C low , F4/80 + phenotype ( Other immune cells play a role in influencing macrophages

Appetite suppression typically begins around week 3 Average weight loss: 3-4% of starting weight Side effects are usually mild at lower starting doses Establishing hydration habits is critical during this phase Most users can eat normally with slightly smaller portions Proactive hydration habits established during month 1 pay dividends later

For comprehensive information about expected weight loss results throughout treatment, see our complete guide to tirzepatide results month by month

Side effects are most pronounced during dose escalation and tend to improve at each dose level as the body adapts before the next increase